Stockscreener 앱 받기
2.96%
전일 마감가:
$358.32
열려 있는:
$358.245
하루 거래량:
771.08K
Relative Volume:
0.30
시가총액:
$199.08B
수익:
$37.30B
순이익/손실:
$7.80B
주가수익비율:
25.66
EPS:
14.3793
순현금흐름:
$8.60B
1주 성능:
+1.46%
1개월 성능:
+6.06%
6개월 성능:
+11.66%
1년 성능:
+23.38%
1일 변동 폭
$357.74
$369.05
1주일 범위
$353.95
$368.95
52주 변동 폭
$269.77
$391.29
암젠 Stock (AMGN) Company Profile
명칭
Amgen Inc
전화
(805)447-1000
주소
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN vs LLY, JNJ, ABBV, MRK, NVS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
368.87 | 193.39B | 37.30B | 7.80B | 8.60B | 14.38 |
LLY
Lilly Eli Co
|
1,174.76 | 1.03T | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
249.86 | 594.63B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
252.23 | 431.29B | 62.82B | 3.60B | 19.98B | 2.0274 |
MRK
Merck Co Inc
|
128.47 | 305.29B | 65.51B | 8.93B | 14.12B | 3.5532 |
NVS
Novartis Ag Adr
|
153.00 | 287.74B | 54.66B | 13.58B | 16.05B | 7.0171 |
암젠 Stock (AMGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-21 | 개시 | Canaccord Genuity | Hold |
| 2026-03-10 | 개시 | Jefferies | Hold |
| 2026-02-20 | 개시 | Barclays | Equal Weight |
| 2026-01-20 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2026-01-07 | 재개 | UBS | Buy |
| 2025-12-05 | 업그레이드 | Erste Group | Hold → Buy |
| 2025-11-24 | 재개 | Truist | Hold |
| 2025-11-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-09-03 | 재개 | Raymond James | Mkt Perform |
| 2025-05-20 | 재개 | Guggenheim | Neutral |
| 2025-04-22 | 재개 | Cantor Fitzgerald | Neutral |
| 2024-12-10 | 재개 | BofA Securities | Underperform |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-14 | 개시 | Citigroup | Neutral |
| 2024-10-17 | 개시 | Bernstein | Outperform |
| 2024-10-14 | 다운그레이드 | Truist | Buy → Hold |
| 2024-09-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-08-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-05-03 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | 재개 | Raymond James | Mkt Perform |
| 2024-02-07 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | 개시 | Deutsche Bank | Hold |
| 2023-11-02 | 업그레이드 | Truist | Hold → Buy |
| 2023-10-20 | 재개 | JP Morgan | Neutral |
| 2023-10-17 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-10-11 | 재개 | BofA Securities | Neutral |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2023-04-24 | 재확인 | Oppenheimer | Outperform |
| 2023-03-13 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | 재확인 | Truist | Buy |
| 2022-11-18 | 개시 | Credit Suisse | Underperform |
| 2022-10-31 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2022-10-11 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | 개시 | SVB Leerink | Mkt Perform |
| 2022-02-09 | 재확인 | Barclays | Equal Weight |
| 2022-02-09 | 재확인 | Jefferies | Buy |
| 2022-02-09 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-02-09 | 재확인 | Oppenheimer | Outperform |
| 2022-02-09 | 재확인 | Wells Fargo | Equal Weight |
| 2022-01-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-12-09 | 재개 | Wells Fargo | Equal Weight |
| 2021-12-06 | 개시 | Goldman | Buy |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-09-23 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | 개시 | Daiwa Securities | Buy |
| 2020-10-28 | 개시 | UBS | Neutral |
| 2020-10-26 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | 업그레이드 | Truist | Hold → Buy |
| 2020-10-09 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | 다운그레이드 | Truist | Buy → Hold |
| 2020-10-08 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | 재개 | Guggenheim | Neutral |
| 2020-03-31 | 개시 | Wolfe Research | Peer Perform |
| 2020-03-30 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | 개시 | Barclays | Equal Weight |
| 2020-01-31 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-12-24 | 개시 | Raymond James | Mkt Perform |
| 2019-12-17 | 재개 | Morgan Stanley | Overweight |
| 2019-11-12 | 개시 | SunTrust | Buy |
| 2019-11-05 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-08-19 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2019-05-23 | 업그레이드 | Citigroup | Neutral → Buy |
모두보기
암젠 주식(AMGN)의 최신 뉴스
Wealthfront Advisers LLC Boosts Position in Amgen Inc. $AMGN - MarketBeat
D.A. Davidson & CO. Trims Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Bank of New York Mellon Corp - MarketBeat
(AMGN) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Landmark ECOG-ACRIN ENDURANCE Study Co-Authored by International Myeloma Foundation Leaders Provides Evidence for Optimal Duration of Maintenance Therapy - GlobeNewswire Inc.
Amgen stock holds steady as biotech pipeline and US revenue base anchor long-term story - Ad Hoc News
Amgen’s Tablet Recalls Test Its Quality Controls and Manufacturing Ambitions (AMGN) - simplywall.st
Livforsakringsbolaget Skandia Omsesidigt Purchases 10,752 Shares of Amgen Inc. $AMGN - MarketBeat
Principal Financial Group Inc. Increases Stock Position in Amgen Inc. $AMGN - MarketBeat
AMG National Trust Bank Has $4.59 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance
Amgen Inc. stock outperforms competitors despite losses on the day - MarketWatch
After Antibiotic Approval, Spero Pivots to Immunology Aiming to Rival an Amgen Asset - MedCity News
Amgen Colo. Win May Chill States' Push To Cap Drug Prices - Law360
Pfizer Vs. Amgen: Bet That Pfizer's Seagen Integration Leads to Long-Term Oncology Alpha Over Amgen - 24/7 Wall St.
Amgen (AMGN) Stock May Be 47% Undervalued After Enbrel Price Cap Ruling - Yahoo Finance
Amgen stock holds steady as biotech pipeline and US market presence shape the long-term story - Ad-hoc-news.de
Amgen Inc. $AMGN Shares Sold by Mattern Capital Management LLC - MarketBeat
Calamos Advisors LLC Buys 3,648 Shares of Amgen Inc. $AMGN - MarketBeat
Advancements in CKD Care: How New Therapies from AstraZeneca, Johnson & Johnson, Novartis, Bayer, and Amgen Are Changing the Landscape - Yahoo Finance Singapore
Bleakley Financial Group LLC Purchases 3,526 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN) Recalls Corlanor And Sensipar Nationwide Over Quality Control Issues - simplywall.st
Amgen Faces a July 29 Deadline to Save Tavneos From an FDA Withdrawal. Here’s What It Means for the Stock. - TIKR.com
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Guggenheim Issues Positive Forecast for Amgen (NASDAQ:AMGN) Stock Price - MarketBeat
Guggenheim raises Amgen stock price target to $343 on product mix - Investing.com
AMGN DCF Analysis: Intrinsic Value $292 vs Price $363 - GuruFocus
BofA raises Amgen stock price target on growth franchise execution By Investing.com - Investing.com Nigeria
BofA raises Amgen stock price target on growth franchise execution - Investing.com
J. Safra Sarasin Holding AG Sells 38,033 Shares of Amgen Inc. $AMGN - MarketBeat
Absher Wealth Management LLC Trims Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen stock holds steady as biotech pipeline and U.S. market presence underpin long-term story - ad-hoc-news.de
Castleview Partners LLC Has $2.77 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Ferguson Wellman Capital Management Inc. - MarketBeat
Cullinan Associates Inc. Has $8.98 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Fifth Third Bancorp Acquires 167,835 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen stock holds steady as investors await the next catalyst - ad-hoc-news.de
Amgen stock steadies as the biotech group leans on scale - ad-hoc-news.de
Amgen Inc. $AMGN Shares Sold by Torray Investment Partners LLC - MarketBeat
Candriam S.C.A. Raises Holdings in Amgen Inc. $AMGN - MarketBeat
Conning Inc. Has $33.85 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen stock holds steady as biotech pipeline and U.S. market listing shape long-term investor expect - ad-hoc-news.de
Amgen's Biotech Crossroads: Congressional Divergence Amid Patent Cliffs and Pipeline Promise - Kavout | AI
ETFs Investing in Amgen Inc. Stocks - TradingView
Amgen stock holds steady as biotech pipeline and U.S. market presence underpin long-term growth narr - ad-hoc-news.de
Amgen stock reflects biotech heavyweight's steady role in US healthcare - ad-hoc-news.de
Munich Reinsurance Co Stock Corp in Munich Sells 2,916 Shares of Amgen Inc. $AMGN - MarketBeat
Ibex Wealth Advisors Increases Stake in Amgen Inc. $AMGN - MarketBeat
First Horizon Corp Boosts Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Regeneron Cites Medtronic Ruling In Amgen Bundling Case - Law360
암젠 (AMGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.38%
0.20%
자본화:
|
볼륨(24시간):